Eli Lilly and Company (LLY) Revenue Growth
Eli Lilly and Company (LLY) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 7.77% |
| 2018-12-31 | -6.03% |
| 2019-12-31 | 3.84% |
| 2020-12-31 | 9.95% |
| 2021-12-31 | 15.40% |
| 2022-12-31 | 0.79% |
| 2023-12-31 | 19.56% |
| 2024-12-31 | 32.00% |
| 2025-12-31 | 44.70% |
How LLY compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IOVA | Iovance Biotherapeutics Inc. | 60.60% |
| NTRA | Natera Inc. | 35.90% |
| KRYS | Krystal Biotech Inc. | 33.94% |
| IONS | Ionis Pharmaceuticals Inc. | 33.83% |
| PODD | Insulet Corporation | 30.73% |
These are five companies in the same sector as LLY with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Eli Lilly and Company Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("LLY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LLY | $1174.61 | -0.13% | 2.45M |
| 3 | ||||
| 4 | ||||
| 5 |